Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Putz

Showing results (71-80 of 75) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 75 results.
Cancer Letters|December 3, 2022
High-content drug screening in zebrafish xenografts reveals high efficacy of dual MCL-1/BCL-X<sub>L</sub> inhibition against Ewing sarcomaSarah Grissenberger, Caterina Sturtzel, Andrea Wenninger-Weinzierl, et al.
Cancer Immunology Research|December 6, 2024
Natural Killer Cell-Mediated Cytotoxicity Shapes the Clonal Evolution of B-cell LeukemiaMichelle C Buri, Mohamed R Shoeb, Aleksandr Bykov, et al.
Nature Communications|May 3, 2024
A human neural crest model reveals the developmental impact of neuroblastoma-associated chromosomal aberrationsIngrid M Saldana-Guerrero, Luis F Montano-Gutierrez, Katy Boswell, et al.
Nature Immunology|December 12, 2023
Author Correction: CIS is a potent checkpoint in NK cell-mediated tumor immunityRebecca B Delconte, Tatiana B Kolesnik, Laura F Dagley, et al.
Nature Immunology|May 24, 2016
CIS is a potent checkpoint in NK cell-mediated tumor immunityRebecca B Delconte, Tatiana B Kolesnik, Laura F Dagley, et al.
Pageof 8

Showing results (71-80 of 75) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 75 results.
Cancer Letters|December 3, 2022
High-content drug screening in zebrafish xenografts reveals high efficacy of dual MCL-1/BCL-X<sub>L</sub> inhibition against Ewing sarcomaSarah Grissenberger, Caterina Sturtzel, Andrea Wenninger-Weinzierl, et al.
Cancer Immunology Research|December 6, 2024
Natural Killer Cell-Mediated Cytotoxicity Shapes the Clonal Evolution of B-cell LeukemiaMichelle C Buri, Mohamed R Shoeb, Aleksandr Bykov, et al.
Nature Communications|May 3, 2024
A human neural crest model reveals the developmental impact of neuroblastoma-associated chromosomal aberrationsIngrid M Saldana-Guerrero, Luis F Montano-Gutierrez, Katy Boswell, et al.
Nature Immunology|December 12, 2023
Author Correction: CIS is a potent checkpoint in NK cell-mediated tumor immunityRebecca B Delconte, Tatiana B Kolesnik, Laura F Dagley, et al.
Nature Immunology|May 24, 2016
CIS is a potent checkpoint in NK cell-mediated tumor immunityRebecca B Delconte, Tatiana B Kolesnik, Laura F Dagley, et al.
Pageof 8